NFE2L2 and neoplasm: The first chemoprevention study to focus on Nrf2-ko mice revealed that whilst 48 h pre-treatment of the mutant mice with oltipraz could decrease the number of benzo[a]pyrene-initiated forestomach neoplastic lesions by approx. 55%, oltipraz did not decrease tumour numbers in Nrf2-ko mice [17].